Express Scripts Gets Discount On AbbVie's Hep C Rx; Covers It Without Restrictions

Express Scripts will only include AbbVie's hepatitis C drug Viekira Pak on its National Preferred Pharmacy formulary in exchange for a “significant” discount on the drug, an Express Scripts spokesman said, and there will be no restrictions to access for the 25 million people on that formulary. Biotech analysts for J.P. Morgan believe the deal marks the beginning of pharmacy benefit managers using exclusionary formularies to cut drug prices. Since Gilead Sciences priced Sovaldi at $84,000 for a 12-week course...